Condition
Hodgkin Disease clinical trials and research
Research outlook What's coming for Hodgkin lymphoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Hodgkin Disease clinical trials that are recruiting, at sites in 4 countries (most in United States (3), Russia (1), Jamaica (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Hodgkin Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| PET-guided first-line nivolumab plus chemotherapy for advanced Hodgkin lymphoma | Phase 2 | Moscow | Recruiting | Oct 6, 2025 |
| Evaluating Spectral CT for Cardiotoxicity in Lymphoma Patients Treated with Anthracyclines | — | Bologna | Recruiting | Jan 14, 2025 |
| CD30-targeted bispecific-antibody‑armed autologous T-cell therapy for relapsed CD30-positive blood cancers | Phase 1 | Milwaukee, Wisconsin | Recruiting | Sep 19, 2022 |
| Collecting biospecimens for cancer research | — | Bethesda, Maryland | Recruiting | Feb 15, 2016 |
| Collecting tissue samples to study lymph cancer | — | Bethesda, Maryland and 1 other locations | Recruiting | Aug 31, 2012 |
All recruiting trials (5)
-
PET-guided first-line nivolumab plus chemotherapy for advanced Hodgkin lymphoma
This pilot trial tests whether adding nivolumab to initial chemotherapy and changing treatment based on an early PET scan helps adults with advanced classical Hodgkin lymphoma.
-
Evaluating Spectral CT for Cardiotoxicity in Lymphoma Patients Treated with Anthracyclines
This study is testing if a special type of CT scan can help find heart damage early in lymphoma patients who are being treated with certain chemotherapy drugs.
-
CD30-targeted bispecific-antibody‑armed autologous T-cell therapy for relapsed CD30-positive blood cancers
This treatment will try using a patient's own T cells armed with a CD30/CD3 bispecific antibody to treat adults with relapsed or refractory CD30-positive blood cancers.
-
Collecting biospecimens for cancer research
This study is collecting blood and tumor samples from adults with cancer to help researchers learn more about the disease and improve treatments.
-
Collecting tissue samples to study lymph cancer
This study is collecting tissue samples from people with lymphoid cancers to learn more about the disease and help create better treatments.
Related topics
Quick answers
How many Hodgkin Disease clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), Russia (1 trial), Jamaica (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.